SPRY
|Silverback Therapeutics Inc
NASDAQ
USD 14.11
-0.42|-2.89%
Current Price
USD 14.11
Change
USD -0.42 (-2.89%)
P/E Ratio
Dividend Yield
Market Cap
1.34B
Volume
324,035
Open
USD 14.50
Previous Close
USD 14.53
52-Week High
USD 18.51
52-Week Low
USD 7.55
About Silverback Therapeutics Inc
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL
Employees:155
Headquarters:San Diego, USA
Website:ars-pharma.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions